Get startedLog in
    Picture of NextCell Pharma AB logo

    NXTCL — NextCell Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: NextCell To Begin Treatment With Medium Dose In COVID-19

    Picture of NextCell Pharma AB logoNextCell Pharma AB
    26/10/2021 12:16
    Oct 26 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * NEXTCELL TO BEGIN TREATMENT WITH MEDIUM DOSE IN COVID-19
    * NEXTCELL ANNOUNCES THAT CLINICAL TRIAL PROTRANS19+SE CAN
COMMENCE TO ENROLL PATIENTS IN MEDIUM DOSE GROUP.

Source text for Eikon:  ID:nWkr4sZbY5 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on NextCell Pharma AB

    See all news